SMN1 and carcinoma: Using immunofluorescence staining, each ROI was segmented into two AOIs (Area of Illumination): the carcinoma AOI (pan-CK+, SMA-) containing only malignant cells, and the TME AOI (pan-CK-, SMA+) which comprised of various types of stroma cells and immune cells (Figure 1B).